Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector through its medical distribution operations, is capturing investor attention with a compelling potential upside of 30.55%. As the company continues..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with its potential for a 61.80% upside, according to..
Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out as a key player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $318.75 million,..
AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on innovative treatments for mental health disorders, is capturing significant attention from investors and analysts alike. Operating primarily in the United..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is turning heads in the healthcare sector with its innovative approach to cancer treatment. Based in Minneapolis, Minnesota, Celcuity focuses on developing..
Tilray Brands, Inc. (NASDAQ: TLRY), a prominent name in the healthcare sector under the specialty and generic drug manufacturers industry, presents an intriguing opportunity for investors willing to navigate the..
SIGA Technologies Inc. (NASDAQ: SIGA), a company at the forefront of the health security market with its leading antiviral product TPOXX, presents a mixed bag for investors. The New York-based..
AngioDynamics, Inc. (NASDAQ: ANGO), a leader in the healthcare sector specializing in medical instruments and supplies, is catching the attention of investors with a noteworthy potential upside of 71.55%, according..
Sana Biotechnology, Inc. (NASDAQ: SANA) presents an intriguing opportunity for investors looking to tap into the burgeoning field of engineered cell therapies. Operating in the healthcare sector, specifically within the..
Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of investors with its promising biotechnology innovations and an impressive potential upside of 154.39% according to analyst ratings. With its core..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a dynamic player in the biotech sector, is capturing the attention of investors with its promising therapeutic developments aimed at countering cancer resistance mechanisms. With..
REGENXBIO Inc. (NASDAQ: RGNX), a notable player in the biotechnology sector, is catching the eyes of investors with a staggering potential upside of 236.78%. Despite the recent challenges faced by..
Rapport Therapeutics, Inc. (RAPP), a burgeoning player in the biotechnology sector, has caught the attention of investors with a significant potential upside of 80.08%. The company’s focus on developing innovative..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage pharmaceutical company, is gaining attention among investors with its promising pipeline of treatments for neurodegenerative diseases and a notable potential upside of 69.27%...
Septerna, Inc. (NASDAQ: SEPN), an emerging player in the biotechnology industry, is garnering attention with its impressive potential upside of 79.58%, according to analyst ratings. This clinical-stage biotech company specializes..
In the ever-evolving landscape of biotechnology, PureTech Health plc (NASDAQ: PRTC) stands out as a dynamic player with a focus on groundbreaking biopharmaceutical solutions. Despite a modest market capitalization of..
Prothena Corporation plc (NASDAQ: PRTA), an emerging player in the biotechnology sector, is currently positioned at an intriguing juncture with a market capitalization of approximately $512.49 million. Headquartered in Dublin,..
Kamada Ltd. (NASDAQ: KMDA), an Israeli healthcare company specializing in plasma-derived protein therapeutics, stands out in the drug manufacturing sector with a promising investment outlook. The company, which has a..
Abivax SA (NASDAQ: ABVX), a French biotechnology firm, is gaining attention from investors with a significant potential upside of 41.76% as indicated by current analyst ratings. Specializing in the healthcare..
